SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-10-095189
Filing Date
2010-10-22
Accepted
2010-10-22 13:35:19
Documents
3
Period of Report
2010-10-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K o65971e8vk.htm 8-K 12397
2 EX-99.1 o65971exv99w1.htm EX-99.1 7789
3 GRAPHIC o65971o6597101.gif GRAPHIC 5569
  Complete submission text file 0000950123-10-095189.txt   29602
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 101136895
SIC: 2835 In Vitro & In Vivo Diagnostic Substances